Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain
Clinical trial NCT06053242 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06053242
- Sponsor
- Creative Medical Technology Holdings Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-21
- Primary completion
- 2027-01-20
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.